Publications | Lund University Publications

1 – 9 of 9

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=keywords+exact+%22Cancer+immunotherapy%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2025
Mark Dendritic Cell Reprogramming for Cancer Immunotherapy
Ascic, Ervin ^LU (2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
2024
Mark Interleukin-1 receptor accessory protein (IL-1RAP) : A magic bullet candidate for immunotherapy of human malignancies
Zarezadeh Mehrabadi, Ali ; Shahba, Faezeh ; Khorramdelazad, Hossein ; Aghamohammadi, Nazanin ; Karimi, Milad ; Bagherzadeh, Kowsar ; Khoshmirsafa, Majid ; Massoumi, Ramin ^LU and Falak, Reza (2024) In Critical Reviews in Oncology/Hematology 193.
- Contribution to journal › Scientific review
2022
Mark Modular design of synthetic receptors for programmed gene regulation in cell therapies
Zhu, Iowis ; Liu, Raymond ; Garcia, Julie M. ; Hyrenius-Wittsten, Axel ^LU ; Piraner, Dan I. ; Alavi, Josef ; Israni, Divya V. ; Liu, Bin ; Khalil, Ahmad S. and Roybal, Kole T. (2022) In Cell 185(8). p.16-1443
- Contribution to journal › Article
2021
Mark Cell Fate Reprogramming in the Era of Cancer Immunotherapy
Zimmermannova, Olga ^LU ; Caiado, Inês ^LU ; Ferreira, Alexandra G. ^LU and Pereira, Carlos Filipe ^LU (2021) In Frontiers in Immunology 12.
- Contribution to journal › Scientific review
Mark The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells, and enhances anti-tumor efficacy of a model cancer vaccine in vivo
Deronic, Adnan ^LU ; Nilsson, Anneli ; Thagesson, Mia ; Werchau, Doreen ; Enell Smith, Karin ^LU and Ellmark, Peter ^LU (2021) In Cancer Immunology, Immunotherapy 70(12). p.3629-3642
- Contribution to journal › Article
2019
Mark Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International Immunocancer Registry (ICIR)
Ramos-Casals, Manel ; Olsson, Peter ^LU and Calabrese, C (2019) In Clinical and Experimental Rheumatology 37. p.114-122
- Contribution to journal › Article
Mark Understanding and Modulating Immunity With Cell Reprogramming
Pires, Cristiana F. ^LU ; Rosa, Fábio F. ^LU ; Kurochkin, Ilia ^LU and Pereira, Carlos Filipe ^LU (2019) In Frontiers in Immunology 10.
- Contribution to journal › Scientific review
2015
Mark TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression
Ho, Victor ; Lim, Tong Seng ; Lee, Justin ; Steinberg, Jeffrey ; Szmyd, Radoslaw ; Tham, Muly ; Yaligar, Jadegoud ; Kaldis, Philipp ^LU ; Abastado, Jean Pierre and Chew, Valerie (2015) In Oncotarget 6(29). p.27252-27266
- Contribution to journal › Article
2007
Mark Clinical-scale generation of strongly CD83-expressing dendritic cells using extracorporeal photopheresis
Bredberg, Anders ^LU ; Jonsson, Svante ^LU ; Lindblom, Anders and Björk, Peter ^LU (2007) In Photodermatology, Photoimmunology & Photomedicine 23(4). p.113-119
- Contribution to journal › Article

your query:: Remove keywords: Cancer immunotherapy